Skip to main content
S&P 5007,811.54+0.59%DOW51,654.95+0.83%NASDAQ27,366.17+0.64%BTC$82,516.00+0.84%ETH$2,488.45+0.36%GOLD$4,220.30+1.52%OIL$91.66+0.19%
Smart Investors Daily
SID Premium
McKesson Corporation logo

NYSE · MCK

McKesson Corporation

Healthcare · Medical - Distribution

$938.84

Up+$8.59 (+0.92%)

Updated Oct 10, 2026, 4:01 PM

SID Score

6.9/10

Composite research score

Smart Money

57/100

Neutral

Market cap
101.96B
P/E ratio
32.2
Dividend yield
0.33%
52-week range
$723.68 – $999.00
Volume
482.92K
Avg. volume
896.08K

Price performance · MCK

MCK price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 9, 2026

MCK closed at $938.84 after 21 trading sessions, up 6.50% for the selected period.

Last close
$938.84
Period change
+6.50%
Period low
$853.81
Period high
$938.84
Daily close
View OHLC price history
MCK OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 9, 2026$927.56$943.97$925.00$938.84482.92K
Oct 8, 2026$906.65$938.51$906.65$930.25715.66K
Oct 7, 2026$924.21$933.99$908.49$910.33794.46K
Oct 6, 2026$921.00$928.46$914.225$921.67680.46K
Oct 5, 2026$905.22$922.46$900.72$915.45697.63K
Oct 2, 2026$899.02$905.55$881.40$902.28777.05K
Oct 1, 2026$886.47$924.21$881.34$898.821.21M
Sep 30, 2026$862.26$866.19$847.30$853.81696.94K
Sep 29, 2026$849.29$866.44$847.285$864.82476.91K
Sep 28, 2026$865.02$871.195$855.64$856.29550.01K
Sep 25, 2026$865.00$871.00$858.76$866.64452.04K
Sep 24, 2026$883.02$896.60$866.59$869.36593.54K
Sep 23, 2026$889.79$907.07$880.50$880.50672.91K
Sep 22, 2026$891.11$897.57$882.88$891.23935.68K
Sep 21, 2026$874.79$895.34$873.3501$886.47940.31K
Sep 18, 2026$872.78$881.05$864.12$874.652.71M
Sep 17, 2026$886.11$889.81$874.73$879.57577.26K
Sep 16, 2026$895.57$897.68$887.29$887.29902.28K
Sep 15, 2026$902.31$907.4975$883.59$899.561.15M
Sep 14, 2026$900.00$912.00$893.38$910.95619.3K
Sep 11, 2026$888.37$893.92$874.31$881.51888.81K

Latest MCK news

The latest Smart Investors Daily articles mentioning MCK.

Stock researchCompany · Overview

MCK research

Overview

Company profile and research snapshot.

Company profile

McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$910.40
Implied upside
—
Analysts
15
MCK recent ratings
DateFirmRatingTarget
Oct 7, 2026Leerink PartnersOutperform—
Sep 14, 2026RBC CapitalSector Perform—
Aug 19, 2026BarclaysOverweight—
Aug 19, 2026RBC CapitalSector Perform—
Aug 11, 2026Wells FargoEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 9, 2026

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson Corporation (NYSE:MCK) is expanding its specialty healthcare operations through a $5.8 billion acquisition (including debt) of Option Care Health, Inc. (NASDAQ:OPCH), partnering with private equity firm Clayton, Dubilier & Rice to take the infusion-services provider private. Announced on October 6, the transaction values Option Care at $32.05 per share, representing a 37% premium to […]

Yahoo · Oct 9, 2026

Option Care Health (OPCH) Faces Legal Review Of Its Proposed Takeover

Option Care Health (NasdaqGS:OPCH) faces shareholder investigations into its proposed sale to Clayton, Dubilier & Rice and McKesson Corporation. Several securities law firms announced probes into whether OPCH's board secured a fair price and process for investors. The legal reviews of the Clayton, Dubilier & Rice and McKesson deal only capture one slice of the Option Care Health story. Our analysis turns up 3 other big wins for Option Care Health as well. For a broader view on income...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By